Which Drug For Which Patient? Is There a Fluoxetine Responding Versus a Bupropion Responding Personality Profile?



D. Stewart Bella, *, W. Mark Shipmanb, **, Mario A. Clevesc, Jill Siegelmand
a Ontario Mental Health Department, Kaiser Permanente, Fontana Medical Center, Ontario, CA United States
b University of California, San Diego, San Diego, CA United States
c Department of Biostatistics, UAMS College of Medicine, Little Rock, AR, United States
d Private Practice, Carlsbad, CA, United States


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 581
Abstract HTML Views: 407
PDF Downloads: 142
Total Views/Downloads: 1130
Unique Statistics:

Full-Text HTML Views: 313
Abstract HTML Views: 230
PDF Downloads: 111
Total Views/Downloads: 654



© Shipman et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at Psychiatry, Kaiser Permanente, 3330 Centrelake Drive, Ontario, CA 91761, United States; Tel: (866) 205-3595; Fax: (909) 974-4701; E-mail: Dwight.S.Bell@kp.org
** Deceased


Abstract

This paper proposes that a certain premorbid personality type – that of hard driving, achievement-oriented, often exercise-oriented individuals – correlates with bupropion response; conversely, patients without these premorbid traits and whose depression is marked by mood swings, irritability and rumination are likely fluoxetine responders.

The authors developed the Fluoxetine Bupropion Assessment Scale (FBAS), a 10-question, self-administered rating scale, to assess these traits and hypothesized that its use would improve outcomes.

A Marriage and Family Therapist (MFT) and a Registered Nurse/Nurse Practitioner (RN/NP) retrospectively reviewed 72 charts from one psychiatrist’s office for two time periods: before and after the psychiatrist utilized the questionnaire to guide antidepressant selection (33 charts before and 39 charts after). Raters were blinded to the theory and to the treatment time period. On the basis of clinical information in the charts, they formulated Clinical Global Impression assessments of treatment response in patients with Beck Depression Inventory scores ≥17 who were not on either drug at the time of intake, and who were prescribed either fluoxetine or bupropion.

The data were in the direction of better results in the FBAS-guided group, particularly after adjusting for age, gender and marital status (efficacy p = 0.087). When global improvement data were combined into three groups describing treatment response (improved, minimal to no improvement, and worse) there were statistically significant better results (p = 0.047) in the FBAS-guided treatment group. Revision and validation of the questionnaire and a larger, randomized study seem indicated.

Keywords: : Bupropion, depression, exercise, fluoxetine, personality, rating scale, selective serotonin reuptake inhibitor, temperament.